Physician
Greene Welch, Jennifer
Greene Welch, Jennifer was paid $154K by Medicaid between Aug 2018 and Jul 2024, across 43 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoGREENE WELCH, JENNIFER
PROVIDENCE, RI 02903
PROVIDENCE, RI 02903
33aNPI1174741656assigned 04/23/2007
33bProvider typePediatric Hematology & Oncology Physician
28Total paid$154K
24GClaims1,915
24DCodes billed43
24AFirst – last monthAug 2018 – Jul 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16 | $408.89 | |
| 2020 | 1,788 | $143K | |
| 2021 | 28 | $2K | |
| 2022 | 33 | $2K | |
| 2023 | 36 | $5K | |
| 2024incomplete | 14 | $2K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 113 | 89 | $35K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 64 | 62 | $28K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 38 | 33 | $20K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 5.8% | 86 | 82 | $9K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.4% | 165 | 132 | $8K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.2% | 33 | 33 | $5K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 3.0% | 36 | 13 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.5% | 20 | 19 | $4K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.2% | 69 | 68 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.1% | 45 | 45 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2.0% | 25 | 20 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 216 | 189 | $3K |
31 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 14 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 40 | $3K |
| 90461 | 1.6% | 42 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 82 | $2K |
| 99213 | Doctor's office visit, returning patient (routine) | 1.3% | 81 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 26 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 18 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 15 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 16 | $1K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 12 | $1K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 38 | $948.10 |
| 80053 | Comprehensive metabolic panel | <1% | 64 | $906.48 |
| 86900 | <1% | 18 | $810.00 | |
| 86850 | <1% | 18 | $775.80 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 24 | $696.21 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 61 | $672.22 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 24 | $598.80 |
| 86901 | <1% | 18 | $545.25 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 139 | $461.16 |
| 99173 | <1% | 26 | $420.42 | |
| 82248 | <1% | 57 | $380.17 | |
| 85027 | <1% | 35 | $354.02 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $299.40 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17 | $226.10 |
| 83690 | <1% | 16 | $138.62 | |
| 85610 | <1% | 21 | $105.94 | |
| 81025 | <1% | 13 | $100.55 | |
| 85730 | <1% | 13 | $96.16 | |
| 82948 | <1% | 17 | $78.40 | |
| 81001 | <1% | 15 | $61.71 | |
| 81003 | <1% | 13 | $27.72 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.